115 related articles for article (PubMed ID: 38932240)
21. Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.
Zeng Z; Zhang R; Hong W; Cheng Y; Wang H; Lang Y; Ji Z; Wu Y; Li W; Xie Y; Cao Z
Theranostics; 2018; 8(1):199-211. PubMed ID: 29290802
[No Abstract] [Full Text] [Related]
22. Antiviral Activity of the G-Quadruplex Ligand TMPyP4 against Herpes Simplex Virus-1.
Artusi S; Ruggiero E; Nadai M; Tosoni B; Perrone R; Ferino A; Zanin I; Xodo L; Flamand L; Richter SN
Viruses; 2021 Jan; 13(2):. PubMed ID: 33525505
[TBL] [Abstract][Full Text] [Related]
23. Computer-Aided Design of Mastoparan-like Peptides Enables the Generation of Nontoxic Variants with Extended Antibacterial Properties.
Oshiro KGN; Cândido ES; Chan LY; Torres MDT; Monges BED; Rodrigues SG; Porto WF; Ribeiro SM; Henriques ST; Lu TK; de la Fuente-Nunez C; Craik DJ; Franco OL; Cardoso MH
J Med Chem; 2019 Sep; 62(17):8140-8151. PubMed ID: 31411881
[TBL] [Abstract][Full Text] [Related]
24. Antifungal Activity, Toxicity, and Membranolytic Action of a Mastoparan Analog Peptide.
Singulani JL; Galeane MC; Ramos MD; Gomes PC; Dos Santos CT; de Souza BM; Palma MS; Fusco Almeida AM; Mendes Giannini MJS
Front Cell Infect Microbiol; 2019; 9():419. PubMed ID: 31867293
[TBL] [Abstract][Full Text] [Related]
25. Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice.
Bhutta MS; Shechter O; Gallo ES; Martin SD; Jones E; Doncel GF; Borenstein R
Viruses; 2021 Jan; 13(1):. PubMed ID: 33435520
[TBL] [Abstract][Full Text] [Related]
26. Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2.
Aboudy Y; Mendelson E; Shalit I; Bessalle R; Fridkin M
Int J Pept Protein Res; 1994 Jun; 43(6):573-82. PubMed ID: 7928088
[TBL] [Abstract][Full Text] [Related]
27. Samarangenin B from Limonium sinense suppresses herpes simplex virus type 1 replication in Vero cells by regulation of viral macromolecular synthesis.
Kuo YC; Lin LC; Tsai WJ; Chou CJ; Kung SH; Ho YH
Antimicrob Agents Chemother; 2002 Sep; 46(9):2854-64. PubMed ID: 12183238
[TBL] [Abstract][Full Text] [Related]
28. Sequence-activity relationship, and mechanism of action of mastoparan analogues against extended-drug resistant Acinetobacter baumannii.
Vila-Farrés X; López-Rojas R; Pachón-Ibáñez ME; Teixidó M; Pachón J; Vila J; Giralt E
Eur J Med Chem; 2015 Aug; 101():34-40. PubMed ID: 26114809
[TBL] [Abstract][Full Text] [Related]
29. Pro-necrotic Activity of Cationic Mastoparan Peptides in Human Glioblastoma Multiforme Cells Via Membranolytic Action.
da Silva AMB; Silva-Gonçalves LC; Oliveira FA; Arcisio-Miranda M
Mol Neurobiol; 2018 Jul; 55(7):5490-5504. PubMed ID: 28965321
[TBL] [Abstract][Full Text] [Related]
30. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.
Jenssen H; Andersen JH; Mantzilas D; Gutteberg TJ
Antiviral Res; 2004 Nov; 64(2):119-26. PubMed ID: 15498607
[TBL] [Abstract][Full Text] [Related]
31. In vitro effect of some nucleoside reverse transcriptase inhibitors against HSV-1 replication.
Nahid Samiei R; Ebrahimi S; Fani M; Ghafari S; Makvandi M; Khodadad N; Tabasi M; Teimoori A
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1454-1459. PubMed ID: 32096195
[TBL] [Abstract][Full Text] [Related]
32. Study of mastoparan analog peptides against
Galeane MC; Gomes PC; L Singulani J; de Souza BM; Palma MS; Mendes-Giannini MJ; Almeida AM
Future Microbiol; 2019 Sep; 14():1087-1097. PubMed ID: 31512522
[No Abstract] [Full Text] [Related]
33. Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan.
Lin CH; Tzen JT; Shyu CL; Yang MJ; Tu WC
Peptides; 2011 Oct; 32(10):2027-36. PubMed ID: 21884742
[TBL] [Abstract][Full Text] [Related]
34. Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide.
Jones S; Howl J
Bioconjug Chem; 2012 Jan; 23(1):47-56. PubMed ID: 22148546
[TBL] [Abstract][Full Text] [Related]
35. Characterization of two novel polyfunctional mastoparan peptides from the venom of the social wasp Polybia paulista.
de Souza BM; da Silva AV; Resende VM; Arcuri HA; Dos Santos Cabrera MP; Ruggiero Neto J; Palma MS
Peptides; 2009 Aug; 30(8):1387-95. PubMed ID: 19463874
[TBL] [Abstract][Full Text] [Related]
36. Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma.
Hilchie AL; Sharon AJ; Haney EF; Hoskin DW; Bally MB; Franco OL; Corcoran JA; Hancock REW
Biochim Biophys Acta; 2016 Dec; 1858(12):3195-3204. PubMed ID: 27693190
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic Potential of Novel Mastoparan-Chitosan Nanoconstructs Against Clinical MDR
Hassan A; Ikram A; Raza A; Saeed S; Zafar Paracha R; Younas Z; Khadim MT
Int J Nanomedicine; 2021; 16():3755-3773. PubMed ID: 34103914
[TBL] [Abstract][Full Text] [Related]
38. Short hairpin-loop-structured oligodeoxynucleotides reduce HSV-1 replication.
Falkenhagen A; Heinrich J; Moelling K
Virol J; 2009 Apr; 6():43. PubMed ID: 19397793
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationship of mastoparan analogs: Effects of the number and positioning of Lys residues on secondary structure, interaction with membrane-mimetic systems and biological activity.
Souza BM; Cabrera MP; Gomes PC; Dias NB; Stabeli RG; Leite NB; Neto JR; Palma MS
Peptides; 2015 Oct; 72():164-74. PubMed ID: 25944744
[TBL] [Abstract][Full Text] [Related]
40. Mastoparan induces apoptosis in B16F10-Nex2 melanoma cells via the intrinsic mitochondrial pathway and displays antitumor activity in vivo.
de Azevedo RA; Figueiredo CR; Ferreira AK; Matsuo AL; Massaoka MH; Girola N; Auada AV; Farias CF; Pasqualoto KF; Rodrigues CP; Barbuto JA; Levy D; Bydlowski SP; de Sá-Junior PL; Travassos LR; Lebrun I
Peptides; 2015 Jun; 68():113-9. PubMed ID: 25305549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
